Home
Conditions
Lung Diseases, Obstructive

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

8,017 public trials 743 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Active, not recruiting

Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population

NCT02967406

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +29 more
Locations: Sanpasitthiprasong Hospital Muaeng, Changwat Ubon Ratchathani, Thailand

View Trial Details

Completed

Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)

NCT07016412

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: SEC Clinical Research, LLC Dothan, Alabama, United States

Elite Clinical Studies, LLC Phoenix, Arizona, United States

Tucson Clinical Research Institute Tucson, Arizona, United States

Downtown LA Research Center Inc - ClinEdge Los Angeles, California, United States

View all 57 locations

View Trial Details

Completed

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patients

NCT07063563

Conditions: Behavior, COPD, Chronic Disease, +8 more
Locations: National center for cardiology and internal medicine Bishkek, Kyrgyzstan

Eastern Switzerland University of Applied Sciences Sankt Gallen, Canton of St. Gallen, Switzerland

View Trial Details

Completed

Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation

NCT07107828

Conditions: Behavior, COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease, +10 more
Locations: National center for cardiology and internal medicine Bishkek, Kyrgyzstan

View Trial Details

Completed

Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control

NCT05168995

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Ospedale dell'Angelo Mestre, VE, Italy

View Trial Details

Completed

Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

NCT06264674

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: "IPSMCPP-D-R Veleva" EOOD Burgas, Bulgaria

Medical Center "Zdrave -1" Kozloduy, Bulgaria

"AIPSMP Yuskyan Aliosman" Ltd Momchilgrad, Bulgaria

Ambulatory for Specialized Outpatient Medical Care - Individual Practice Rousse, Bulgaria

View all 118 locations

View Trial Details

Completed

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)

NCT02123667

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Chiesi Clinical Trial Site #0503 Denver, Colorado, United States

Chiesi Clinical Trial Site #0502 Durham, North Carolina, United States

Chiesi Clinical Trial Site #0504 Cleveland, Ohio, United States

Chiesi Clinical Trial Site #0501 Houston, Texas, United States

View all 26 locations

View Trial Details

Completed

Oxygen Therapy During Exercise Training in Inpatient Rehabilitation in Chronic Lung Disease- Does it Matter?

NCT07044843

Conditions: Behavior, COPD, Chronic Disease, +8 more
Locations: National center for cardiology and internal medicine Bishkek, Kyrgyzstan

Eastern Switzerland University of Applied Sciences Sankt Gallen, Canton of St. Gallen, Switzerland

View Trial Details

Completed

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT02546700

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations: Achieve Clinical Research, LLC Birmingham, Alabama, United States

California Medical Research Associates, Inc. Northridge, California, United States

Palmtree Clinical research Inc Palm Springs, California, United States

Finlay Medical Research Miami, Florida, United States

View all 63 locations

View Trial Details

Completed

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.

NCT07116915

Conditions: COPD, Chronic Disease, Disease Attributes, +6 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Lung Diseases, Obstructive

Lung Diseases, Obstructive trial results

Related conditions